{
  "version": "2025-08-22-2",
  "disclaimer": "This is a guide only – follow the advice of your healthcare professional.",
  "footerByClass": {
    "Opioid": {
      "expectedBenefits": "Improved function and reduced opioid-related harms.",
      "withdrawal": "Transient pain flare, cravings, mood changes."
    },
    "Benzodiazepines / Z-Drug (BZRA)": {
      "expectedBenefits": "Improved cognition, daytime alertness, and reduced falls.",
      "withdrawal": "Insomnia, anxiety, irritability."
    },
    "Antipsychotic": {
      "expectedBenefits": "Lower risk of metabolic/extrapyramidal adverse effects.",
      "withdrawal": "Sleep disturbance, anxiety, return of target symptoms."
    },
    "Proton Pump Inhibitor": {
      "expectedBenefits": "Review at 4–12 weeks; incorporate non-drug strategies (sleep, diet, positioning).",
      "withdrawal": "Rebound heartburn."
    }
  },
  "practiceText": {
    "default": "Swallow whole, do not halve or crush.",
    "byClass": {
      "Benzodiazepines / Z-Drug (BZRA)": "",
      "Antipsychotic": ""
    },
    "byForm": {
      "Patch": "Apply to intact skin as directed. Do not cut patches.",
      "Orally Dispersible Tablet": "The orally dispersible tablet can be dispersed in the mouth."
    },
    "byMedicineForm": {
      "Lansoprazole|Orally Dispersible Tablet": "The orally dispersible tablet can be dispersed in the mouth."
    }
  }
}
